Boc-DL-Ala-OH

Boc-DL-Ala-OH is a Boc-protected alanine derivative supplied as a DL mixture, combining a tert-butoxycarbonyl (Boc) group on the amino functionality with a free carboxylic acid. As an amino acid building block, it is commonly used in peptide and peptidomimetic intermediate synthesis workflows where controlled reactivity of the amino group is required while retaining the carboxylic acid for subsequent coupling or activation. The presence of a stereochemical DL mixture supports use cases focused on chemical assembly and intermediate generation rather than stereochemically defined biological incorporation.

1. Peptide Intermediate Coupling

Boc-DL-Ala-OH is frequently used by peptide synthesis teams to prepare alanine-containing segments and intermediates where the amino group is protected as Boc to enable stepwise assembly. Researchers developing short peptides, peptide fragments, or peptidomimetic scaffolds often select this building block when they need a protected alanine unit that can be coupled through the carboxylic acid functionality in downstream transformations. The Boc protection supports routine peptide-manufacturing workflows in which the protected amino group remains masked during coupling steps, allowing controlled progression of sequence assembly.

2. Solution-Phase Peptidomimetic Assembly

Boc-DL-Ala-OH is also applied in solution-phase peptide chemistry and peptidomimetic development, particularly in laboratories that build linear structures through iterative activation and coupling of amino acid derivatives. Because the carboxylic acid is available for activation and the amino group is protected, this reagent fits well into workflows that generate protected intermediates prior to final deprotection and purification. The DL stereochemical character is commonly leveraged in chemical library or exploratory synthesis contexts where stereochemical purity at the alanine position is not the primary determinant of the target structure, and the focus is on obtaining sufficient material for subsequent derivatization and characterization.

3. Pharmaceutical Intermediate Development

Boc-DL-Ala-OH is used as an alanine-based chiral building block precursor in pharmaceutical intermediate development programs that require Boc-protected amino acid functionality. Process chemistry and medicinal chemistry groups often incorporate Boc-protected amino acid motifs into larger intermediates to enable later functional group manipulations, including conversion of the carboxylic acid into activated derivatives for further coupling chemistry. The reagent's protected amine and free acid pattern makes it a practical input for constructing amide-containing intermediates and related nitrogen-bearing fragments used in the synthesis of complex small molecules and peptide-like candidates.

4. Analytical Reference Material Preparation

Boc-DL-Ala-OH is applied in analytical method development and reference material preparation for laboratories that require a defined Boc-protected alanine derivative as a standard or control compound. Analytical chemists use such protected amino acid standards to validate chromatographic behavior, retention-time assignments, and derivatization/coupling performance in workflows that monitor protected amino acid intermediates. The DL mixture can be advantageous when the analytical method targets total Boc-protected alanine content or when stereochemical separation is not required for method qualification and routine sample comparison.

1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

3. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

4. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

5. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes